Relebactam

Relebactam is used as part of a combination antibiotic (with imipenem/cilastatin) to treat serious bacterial infections, especially those caused by multidrug-resistant (MDR) Gram-negative bacteria, including complicated urinary tract infections (cUTIs), complicated intra-abdominal infections (cIAIs), and hospital-acquired/ventilator-associated pneumonia (HABP/VABP). It works by protecting imipenem from bacterial enzymes (beta-lactamases), restoring its ability to kill resistant bacteria like Pseudomonas aeruginosa and carbapenem-resistant Enterobacterales (CRE). The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include relebactamum, (1R, 2S, 5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1 and 6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate. Its PubChem CID is 44129647.

CAS No 1174018-99-5
Molecular Formula C12H20N4O6S
Molecular Weight 348.38 g/mol
Synonyms [(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate

Frequently Asked Questions